Choosing care · Updated October 6, 2026
Name the exact intervention
“Stimulation” can refer to spinal cord or peripheral nerve systems with different targets and equipment. “IV therapy” names a route, not a drug or proven effect. Ask for the specific product, procedure, target condition and intended outcome. A claim about a category may not apply to the treatment being proposed.
If a device is described as FDA approved, ask for the model and approved indication. FDA's overview of one spinal cord stimulator does not establish the indication for every system, and a treatment listed by a clinic is not automatically approved for every condition.
Compare claim and evidence
Ask whether the evidence comes from a product label, clinical guideline, controlled study or individual experience. A study may concern different patients, a different anatomical target or only short follow-up. Professional guidance for sacroiliac pain describes uncertainty for many questions, so certainty in an advertisement deserves a closer look.
Check the regulatory and coverage limits
FDA warns that regenerative therapies are not approved to treat chronic pain. That matters when a clinic lists stem-cell services without identifying the product or indication. Medicare coverage criteria, when available, answer a payment question; they do not by themselves show that an intervention will help an individual. Ask for the key benefits, harms, alternatives and out-of-pocket obligation in writing before agreeing to a service.
Questions to ask
- What exact product or procedure is proposed?
- What evidence applies to my diagnosis?
- Is this product approved for this use?
- What important uncertainty or cost remains?